Lung injury caused by paraquat poisoning results in increased interleukin‑6 and decreased microRNA‑146a levels

Wu,Wei; Li,Yong

doi:10.3892/etm.2018.6153

Lung injury caused by paraquat poisoning results in increased interleukin‑6 and decreased microRNA‑146a levels

Authors:
- Wei Wu
- Yong Li
View Affiliations

Affiliations: Department of Respiratory Medicine, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China, Emergency Department, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China
Published online on: May 11, 2018 https://doi.org/10.3892/etm.2018.6153
Pages: 406-412

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the expression of microRNA (miR)‑146a in the pulmonary macrophages, peripheral blood mononuclear cells and serum of patients with lung injury caused by paraquat poisoning, as well as the underlying mechanism of its regulation in the disease. A total of 26 patients with lung injury caused by paraquat poisoning were included in the present study. In addition, 33 healthy subjects were included as the control group. The expression levels of interleukin (IL)‑6 mRNA and miR‑146a was determined by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). Western blotting was used to measure IL‑6 protein expression, while enzyme‑linked immunosorbent assay was also performed to determine the secretion of IL‑6 protein. A dual‑luciferase reporter assay was conducted to examine whether IL‑6 mRNA is a direct target of miR‑146a. Patients with lung injury caused by paraquat poisoning exhibited higher IL‑6 mRNA and protein levels as compared with those in healthy subjects. In addition, miR‑146a expression in patients with paraquat poisoning‑induced lung injury was significantly reduced in comparison with that in healthy subjects. Notably, the overexpression of miR‑146a by mimic transfection downregulated the expression of IL‑6 in pulmonary macrophages. The results of dual‑luciferase reporter assay demonstrated that IL‑6 mRNA was a direct target of miR‑146a. Therefore, the present study demonstrated that increased expression of IL‑6 in patients with lung injury caused by paraquat poisoning is associated with decreased expression of miR‑146a. Furthermore, miR‑146a may regulate the occurrence and immune response of lung injury caused by paraquat poisoning and this process is possibly achieved via IL‑6, an important cytokine that mediates inflammation.

View Figures

View References

1	Mullick FG, Ishak KG, Mahabir R and Stromeyer FW: Hepatic injury associated with paraquat toxicity in humans. Liver. 1:209–221. 1981. View Article : Google Scholar : PubMed/NCBI
2	Nagao M, Takatori T, Inoue K, Shimizu M, Terazawa K and Akabane H: Immunohistochemical localization and dynamics of paraquat in small intestine, liver and kidney. Toxicology. 63:167–182. 1990. View Article : Google Scholar : PubMed/NCBI
3	Dinis-Oliveira RJ, Remião F, Duarte JA, Ferreira R, Navarro Sánchez A, Bastos ML and Carvalho F: P-glycoprotein induction: An antidotal pathway for paraquat-induced lung toxicity. Free Radic Biol Med. 41:1213–1224. 2006. View Article : Google Scholar : PubMed/NCBI
4	Hwang KY, Lee EY and Hong SY: Paraquat intoxication in Korea. Arch Environ Health. 57:162–166. 2002. View Article : Google Scholar : PubMed/NCBI
5	Yamashita M, Yamashita M and Ando Y: A long-term follow-up of lung function in survivors of paraquat poisoning. Hum Exp Toxicol. 19:99–103. 2000. View Article : Google Scholar : PubMed/NCBI
6	Anderson AE, Pratt AG, Sedhom MA, Doran JP, Routledge C, Hargreaves B, Brown PM, Cao Lê KA, Isaacs JD and Thomas R: IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis. Ann Rheum Dis. 75:466–473. 2016. View Article : Google Scholar : PubMed/NCBI
7	Tezono K, Sarker KP, Kikuchi H, Nasu M, Kitajima I and Maruyama I: Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: Production of IL-6 and IL-8 in monocytes by fibrin clots. Haemostasis. 31:71–79. 2001.PubMed/NCBI
8	Vila N, Reverter JC, Yagüe J and Chamorro A: Interaction between interleukin-6 and the natural anticoagulant system in acute stroke. J Interferon Cytokine Res. 20:325–329. 2000. View Article : Google Scholar : PubMed/NCBI
9	Xu Z, Xiao SB, Xu P, Xie Q, Cao L, Wang D, Luo R, Zhong Y, Chen HC and Fang LR: miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB. J Biol Chem. 286:21401–21412. 2011. View Article : Google Scholar : PubMed/NCBI
10	Sonkoly E, Ståhle M and Pivarcsi A: MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol. 18:131–140. 2008. View Article : Google Scholar : PubMed/NCBI
11	Ye EA and Steinle JJ: miR-146a suppresses STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in primary human retinal microvascular endothelial cells in high glucose conditions. Vision Res. 139:15–22. 2017. View Article : Google Scholar : PubMed/NCBI
12	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
13	Aspelund Stjärne A, Hammarström H, Inghammar M, Larsson H, Hansson L, Christensson B and Påhlman LI: Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients. Am J Transplant. 18:444–452. 2018. View Article : Google Scholar : PubMed/NCBI
14	He X, Ping J and Wen D: MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C. Exp Ther Med. 14:3253–3258. 2017. View Article : Google Scholar : PubMed/NCBI
15	Wu H, Song J and Ma J: Paraquat is approved for continued use in the European Union. Pest Sci Administ. 25:36–37. 2004.
16	Yamamoto M, Toda M, Tanaka K, Sugita T, Sasaki S, Uneyama C and Morikawa K: Study on usage of pesticides in various countries. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 92–100. 2007.PubMed/NCBI
17	Tang YH, Vital S, Russell J, Seifert H and Granger DN: Interleukin-6 mediates enhanced thrombus development in cerebral arterioles following a brief period of focal brain ischemia. Exp Neurol. 271:351–357. 2015. View Article : Google Scholar : PubMed/NCBI
18	Suzuki Y, Matsui T, Ito H, Ashida T, Nakamura S, Motoya S, Matsumoto T, Sato N, Ozaki K, Watanabe M and Hibi T: Circulating interleukin 6 and albumin, and infliximab levels are good predictors of recovering efficacy after dose escalation infliximab therapy in patients with loss of response to treatment for crohn's disease: A prospective clinical trial. Inflamm Bowel Dis. 21:2114–2122. 2015. View Article : Google Scholar : PubMed/NCBI
19	Schaper F and Rose-John S: Interleukin-6: Biology, signaling and strategies of blockade. Cytokine Growth Factor Rev. 26:475–487. 2015. View Article : Google Scholar : PubMed/NCBI
20	Liz J and Esteller M: lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
21	Varshney J and Subramanian S: MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics. Front Mol Biosci. 2:312015. View Article : Google Scholar : PubMed/NCBI
22	Abou-Zeid A, Saad M and Soliman E: MicroRNA 146a expression in rheumatoid arthritis: Association with tumor necrosis factor-alpha and disease activity. Genet Test Mol Biomarkers. 15:807–812. 2011. View Article : Google Scholar : PubMed/NCBI
23	Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH and Chan EK: Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther. 10:R1012008. View Article : Google Scholar : PubMed/NCBI
24	Li X, Kroin JS, Kc R, Gibson G, Chen D, Corbett GT, Pahan K, Fayyaz S, Kim JS, van Wijnen AJ, et al: Altered spinal microRNA-146a and the microRNA-183 cluster contribute to osteoarthritic pain in knee joints. J Bone Miner Res. 28:2512–2522. 2013. View Article : Google Scholar : PubMed/NCBI
25	Li X, Gibson G, Kim JS, Kroin J, Xu S, van Wijnen AJ and Im HJ: MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene. 480:34–41. 2011. View Article : Google Scholar : PubMed/NCBI
26	Yamasaki K, Nakasa T, Miyaki S, Ishikawa M, Deie M, Adachi N, Yasunaga Y, Asahara H and Ochi M: Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum. 60:1035–1041. 2009. View Article : Google Scholar : PubMed/NCBI
27	Larner-Svensson HM, Williams AE, Tsitsiou E, Perry MM, Jiang X, Chung KF and Lindsay MA: Pharmacological studies of the mechanism and function of interleukin-1beta-induced miRNA-146a expression in primary human airway smooth muscle. Respir Res. 11:682010. View Article : Google Scholar : PubMed/NCBI
28	Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC and Flemington EK: Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol. 82:1946–1958. 2008. View Article : Google Scholar : PubMed/NCBI
29	Taganov KD, Boldin MP, Chang KJ and Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006. View Article : Google Scholar : PubMed/NCBI
30	Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V and Macino G: An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood. 115:265–273. 2010. View Article : Google Scholar : PubMed/NCBI